Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
VHAQ.RT was delisted on the 20th of February, 2024.
25 hedge funds and large institutions have $484K invested in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
7% less funds holding
Funds holding: 27 → 25 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
71% less capital invested
Capital invested by funds: $1.65M → $484K (-$1.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$27.8K |
| 2 |
CS
Clear Street
New York
|
+$24.2K |
| 3 |
CAC
Cowen and Company
New York
|
+$19.5K |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$10.4K |
| 5 |
Millennium Management
New York
|
+$3.94K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$94.3K |
| 2 |
BCM
Bluefin Capital Management
New York
|
-$39.3K |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$30.4K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$30.1K |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$4.57K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $6 | +$11 | +120 | New |
|
|
KPF
27
K2 Principal Fund
Toronto,
Ontario, Canada
| – | -$94.3K | -722,804 | Closed |
|
|
28
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$30.1K | -230,989 | Closed |
|
VHAQ.RT Hedge Fund Activity: Q1 2023 in Review
25 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) for Q1 2023, worth a combined $484K — down 71% from $1.65M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VHAQ.RT and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 6 added.
The largest buyer was Radcliffe Capital Management, adding an estimated $27.8K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $94.3K sold.
- 25 institutional investors held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) as of Q1 2023, down from 27 in Q4 2022.
- Funds reported $484K of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock stock for Q1 2023, down 71% quarter-over-quarter.
- 2 funds opened new Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock positions in Q1 2023 and 3 closed out, a net change of -1 holder.
- The largest Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock buyer in Q1 2023 was Radcliffe Capital Management, an estimated $27.8K added.
- The largest Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock seller in Q1 2023 was K2 Principal Fund, an estimated $94.3K sold.
Based on aggregated 13F filings for Q1 2023.